Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Breyer

Showing results (21-30 of 234) with videos related to

Pageof 24
Sort By:
Nature Reviews. Drug Discovery|May 28, 2016
The next generation of therapeutics for chronic kidney diseaseMatthew D Breyer, Katalin Susztak
Kidney International. Supplement|December 1, 1996
Effect of vasopressin on intracellular Na+ concentration in cortical collecting ductM D Breyer, D Fredin
Journal of the American Society of Nephrology : JASN|April 24, 2023
Tackling AKIRajashree Rana, Matthew D Breyer
American Journal of Physiology. Renal Physiology|June 16, 2001
Physiological regulation of cyclooxygenase-2 in the kidneyR C Harris, M D Breyer
Clinical Journal of the American Society of Nephrology : CJASN|March 21, 2020
The Use of Genomics to Drive Kidney Disease Drug Discovery and DevelopmentDermot F Reilly, Matthew D Breyer
Diabetes Care|September 1, 1995
A simplified method of blood sampling for diabetes controlD Breyer, J Humski, R Mesić
Current Opinion in Nephrology and Hypertension|February 24, 2001
Cyclooxygenase 2 and the kidneyM D Breyer, R C Harris
Annual Review of Physiology|February 22, 2001
G protein-coupled prostanoid receptors and the kidneyM D Breyer, R M Breyer
American Journal of Physiology. Renal Physiology|July 15, 2000
Prostaglandin E receptors and the kidneyM D Breyer, R M Breyer
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Update on cyclooxygenase-2 inhibitorsRaymond C Harris, Matthew D Breyer
Pageof 24

Showing results (21-30 of 234) with videos related to

Sort By:
Pageof 24
Nature Reviews. Drug Discovery|May 28, 2016
The next generation of therapeutics for chronic kidney diseaseMatthew D Breyer, Katalin Susztak
Kidney International. Supplement|December 1, 1996
Effect of vasopressin on intracellular Na+ concentration in cortical collecting ductM D Breyer, D Fredin
Journal of the American Society of Nephrology : JASN|April 24, 2023
Tackling AKIRajashree Rana, Matthew D Breyer
American Journal of Physiology. Renal Physiology|June 16, 2001
Physiological regulation of cyclooxygenase-2 in the kidneyR C Harris, M D Breyer
Clinical Journal of the American Society of Nephrology : CJASN|March 21, 2020
The Use of Genomics to Drive Kidney Disease Drug Discovery and DevelopmentDermot F Reilly, Matthew D Breyer
Diabetes Care|September 1, 1995
A simplified method of blood sampling for diabetes controlD Breyer, J Humski, R Mesić
Current Opinion in Nephrology and Hypertension|February 24, 2001
Cyclooxygenase 2 and the kidneyM D Breyer, R C Harris
Annual Review of Physiology|February 22, 2001
G protein-coupled prostanoid receptors and the kidneyM D Breyer, R M Breyer
American Journal of Physiology. Renal Physiology|July 15, 2000
Prostaglandin E receptors and the kidneyM D Breyer, R M Breyer
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Update on cyclooxygenase-2 inhibitorsRaymond C Harris, Matthew D Breyer
Pageof 24